Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VIYASH SCIENTIFIC LIMITED Call Transcript 2026

Feb 3, 2026

62287_rns_2026-02-03_67a6f5f4-6b15-46aa-8d37-97ce90a02f88.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [136 x 56] intentionally omitted <==

Viyash Scientific Limited

(Formerly known as Sequent Scientific Limited) Registered Office: 3[rd] Floor, Srivalli’s Corporate, Plot No.290, Road No.6, Sy.No.33, 34P to 39, Guttala Begumpet, Jubilee Hills, Hyderabad, Shaikpet, Telangana, India-500033 T: +91 40 23635000, E:[email protected] E: [email protected] Website: www.sequent.in CIN: L99999TS1985PLC196357

February 03, 2026

To, BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex, Dalal Street, Fort, Bandra (East), Mumbai – 400 001 Mumbai – 400 051 Scrip code: 512529 Symbol: SEQUENT

Subject: Intimation of Conference call – Update

Dear Sir/Madam,

Further to our intimation dated January 21, 2026, regarding the conference call with Analysts/Investors, we wish to inform you that the said conference call to discuss the Company’s Q3FY26 financial results, has been rescheduled at 5:30 p.m. (IST), on Friday, February 06, 2026.

The details of the said rescheduled conference call are enclosed herewith and are also available on the Company’s website under the Investors section at: www.sequent.in.

You are requested to take the same on record.

Yours faithfully,

For Viyash Scientific Limited (Formerly known as Sequent Scientific Limited)

Vora Digitally signed by Vora Yoshita Yoshita Susmit Susmit Date: 2026.02.03 16:26:32 +05'30'

Yoshita Vora Company Secretary & Compliance Officer Encl: A/a

Viyash Scientific Limited (Formerly known as Sequent Scientific Limited ) Q3FY26 Earnings Call Friday, 6[th] February 2026, 5:30 PM IST

==> picture [156 x 56] intentionally omitted <==

Viyash Scientific Ltd. invites you to interact with the senior management on Q3FY26 earnings.

Speakers:

Dr. Hari Babu Bodepudi, Managing Director & Group CEO Mr. Rajaram Narayanan, Executive Director and CEO – Animal Health Mr. Ramakant Singani, Chief Financial Officer

Conference Call Details

Dial in Details: For Viyash’s conference call, Friday 6[th] February 2026, 5:30 pm IST Universal Access +91 22 6280 1263 +91 22 7115 8213 DiamondPass Click here (for early registration)